Cencora (COR)
268.80
0.96 (0.36%)
At close: Mar 21, 2025, 2:56 PM
0.36% (1D)
| Bid | 268.66 |
| Market Cap | 52.12B |
| Revenue (ttm) | 303.44B |
| Net Income (ttm) | 1.4B |
| EPS (ttm) | 7.04 |
| PE Ratio (ttm) | 38.18 |
| Forward PE | 15.38 |
| Analyst | Buy |
| Ask | 268.95 |
| Volume | 1,140,691 |
| Avg. Volume (20D) | 1,461,281 |
| Open | 268.17 |
| Previous Close | 267.84 |
| Day's Range | 266.54 - 271.15 |
| 52-Week Range | 214.77 - 271.07 |
| Beta | 0.50 |
About COR
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pha...
Industry Medical - Distribution
Sector Healthcare
IPO Date Apr 4, 1995
Employees 46,000
Stock Exchange NYSE
Ticker Symbol COR
Analyst Forecast
According to 9 analyst ratings, the average rating for COR stock is "Buy." The 12-month stock price forecast is $282.5, which is an increase of 5.10% from the latest price.
Stock ForecastsNext Earnings Release
Cencora is scheduled to release its earnings on Apr 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+2.96%
Cencora shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
-3.93%
Cencora shares are trading lower after Walgreens lowered its outlook and announced store closure.
